136 related articles for article (PubMed ID: 34174419)
1. Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
Carvalho J; Lopes-Nunes J; Vialet B; Rosado T; Gallardo E; Vale J; Eloy C; Ferreira S; Palmeira-de-Oliveira R; Campello MPC; Paulo A; Barthélémy P; Mergny JL; Salgado GF; Queiroz JA; Ellington AD; Cruz C
Nanomedicine; 2021 Aug; 36():102429. PubMed ID: 34174419
[TBL] [Abstract][Full Text] [Related]
2. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-guided acridine derivatives for cervical cancer.
Carvalho J; Lopes-Nunes J; Lopes AC; Cabral Campello MP; Paulo A; Queiroz JA; Cruz C
Org Biomol Chem; 2019 Mar; 17(11):2992-3002. PubMed ID: 30810582
[TBL] [Abstract][Full Text] [Related]
5. Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
Xu G; Yu X; Zhang J; Sheng Y; Liu G; Tao W; Mei L
Int J Nanomedicine; 2016; 11():2953-65. PubMed ID: 27382282
[TBL] [Abstract][Full Text] [Related]
6. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
7. Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.
Ogloblina AM; Iaccarino N; Capasso D; Di Gaetano S; Garzarella EU; Dolinnaya NG; Yakubovskaya MG; Pagano B; Amato J; Randazzo A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096752
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-Directed Specific Drug Delivery and Magnetic Resonance Imaging of Renal Carcinoma Cells In Vitro and In Vivo.
Li J; Wang J; Sun D; Dai Y; Shen J; You J; Han C; Xu K
J Biomed Nanotechnol; 2016 Aug; 12(8):1604-616. PubMed ID: 29342341
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
10. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
[TBL] [Abstract][Full Text] [Related]
11. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
Mehrnia SS; Hashemi B; Mowla SJ; Nikkhah M; Arbabi A
Radiat Oncol; 2021 Feb; 16(1):33. PubMed ID: 33568174
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
[TBL] [Abstract][Full Text] [Related]
14. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
[TBL] [Abstract][Full Text] [Related]
15. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Functionalized Gold Nanoparticles for Drug Delivery to Gynecological Carcinoma Cells.
Lopes-Nunes J; Agonia AS; Rosado T; Gallardo E; Palmeira-de-Oliveira R; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Fonseca-Moutinho J; Campello MPC; Paiva A; Paulo A; Vulgamott A; Ellignton AD; Oliveira PA; Cruz C
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439193
[TBL] [Abstract][Full Text] [Related]
17. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
19. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
Reyes-Reyes EM; Teng Y; Bates PJ
Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190
[TBL] [Abstract][Full Text] [Related]
20. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]